Gilead Sciences (GILD) closed at $151.17 in the latest trading session, marking a +2.77% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.6%. Elsewhere, ...

Plants express diverse small GTP-binding proteins including Ras-associated binding (RAB) proteins that direct membrane trafficking and Rho-of-plant (ROP) proteins that mostly regulate cytoskeletal ...

VANCOUVER, British Columbia-- (BUSINESS WIRE)--Life Sciences BC (LSBC) is proud to announce the companies selected for its ...

Oct 7 (Reuters) - Life sciences company Danaher said on Wednesday it plans to launch its first AI-powered autonomous research lab early next year to make drug discovery and development faster and more ...

The arrangement will see Cognizant combine its life sciences knowledge with technical services to aid Gilead's processes.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment of ...